Intellia Therapeutics, Inc. (NTLA)

13.44 +0.29 (+2.21%) USD  |  NASDAQ  |  Mar 06, 16:00
13.39 -0.05 (-0.37%) After-Hours: 20:00
More

Intellia Therapeutics Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Personalis, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade